One-year survival rates are similar for transplant patients who receive a heart from a donor with hepatitis C or one without the infectious virus, a new study finds.
Using lungs for transplant from donors who are considered at high risk for certain infectious diseases has similar one-year outcomes for recipients compared with using lungs from standard-risk donors ...
The Pfizer Foundation announced 20 grants* to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases...